Home > News  > Archive

News Archive

Media News Archive

January 2010
Herceptin now approved in the EU for patients with HER2-positive advanced stomach cancer   more..

Roche invests about 190 Mio Swiss Francs in infusion-free administration device with new Herceptin formulation   more..

FDA approves ACTEMRA for the treatment of moderately to severely active rheumatoid arthritis   more..

Xeloda® in combination with oxaliplatin filed in Europe for the adjuvant treatment of patients with early colon cancer   more..
December 2009
Greater chances of cure for patients with HER2-positive early breast cancer when treated with one year of Herceptin   more..

Avastin plus commonly used chemotherapies improves time without the disease getting worse in women with previously treated advanced breast cancer   more..

Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab in rheumatoid arthritis   more..

Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae   more..

Important progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1   more..

MabThera/Rituxan is the first treatment to show improved overall survival in previously untreated patients with chronic lymphocytic leukemia   more..

MabThera/Rituxan: promising new data in leukemia and lymphatic cancers to be presented at the American Society of Hematology (ASH), the world's leading meeting in blood cancers   more..
October 2009
ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone   more..

Roche reports further accelerated sales growth in third quarter   more..
September 2009
Herceptin provides impressive survival benefit for patients with high levels of HER2 in their stomach cancer   more..

From inoperable disease to potentially life saving surgery - new Avastin data gives hope to colorectal cancer patients with liver metastases   more..

Roche announces results from two early studies which show promise for patients with malignant melanoma   more..

Avastin could play an important role in improving the daily lives of patients with the most aggressive form of brain cancer   more..

Two new studies report increased survival rates in Tamiflu-treated patients with avian flu (H5N1) and severe seasonal flu   more..

Roche recognised as new Super Sector Leader in Dow Jones Sustainability Index   more..

MabThera approved in Europe for use in patients with previously-treated chronic lymphocytic leukaemia   more..

Roche receives CE Mark certification for cobas 8000 modular analyzer series   more..
August 2009
Avastin plus commonly used chemotherapies improves time without the disease getting worse in women with previously treated advanced breast cancer   more..

Fragile X Syndrome: Translating knowledge into real therapies   more..

Discussing the (as yet) untested business case behind PHC   more..

Avastin approved in US for the most common type of kidney cancer   more..
July 2009
Second Phase III Study Showed Lucentis Improved Vision in Patients with Retinal Vein Occlusion   more..

European commission approves broader label for Avastin allowing combination with docetaxel for the first-line treatment of advanced (metastatic) breast cancer   more..

MabThera receives positive opinion in Europe for treating patients whose chronic lymphocytic leukaemia returns   more..

Xeloda in combination with oxaliplatin shown to be effective in early colon cancer   more..

PHC in Practice - Pharma and Diagnostics collaborate to prove medical value of new CMV test   more..

New data from phase III SATURN study shows Tarceva improves overall survival when used immediately after initial chemotherapy in patients with advanced lung cancer   more..

PHC in Practice - Roche improving HER2 testing for breast and gastric cancer   more..

Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion   more..
May 2009
Herceptin landmark study (ToGA) reveals unprecedented survival benefit in HER2-positive stomach cancer   more..

Maintenance treatment with Avastin and Tarceva in combination helps lung cancer patients live longer without their disease worsening   more..

Full results from first Phase III study of Avastin in adjuvant colon cancer announced   more..

Two-year data reinforce effectiveness of ACTEMRA in inhibiting joint damage and improving physical function in patients with rheumatoid arthritis   more..

Roche to present major advances with targeted cancer medicines at ASCO   more..

Important New Treatment Option Approved in US for Patients with the Most Aggressive Form of Brain Cancer   more..
April 2009
Roche strongly outperforms market in first quarter   more..

Roche Diabetes Care supports "Changing Diabetes in Children"   more..

Roche to introduce new LightCycler MRSA Advanced Test in the EU   more..
March 2009
Herceptin now shown to significantly prolong the lives of patients with HER2-positive advanced stomach cancer   more..

Roche acquires innovatis AG to complement its product portfolio in the rapidly growing area of cellular analytics   more..

Roche and Genentech reach a friendly agreement to combine the two organizations and create a leader in healthcare innovation   more..

Herceptin proven to benefit women with HER2 positive early breast cancer latest results from the HERA study   more..
February 2009
MabThera approved in the EU for patients with chronic lymphocytic leukaemia   more..

For the first time, doctors can predict which hepatitis B patients have the highest chance to achieve treatment success with Pegasys   more..

Strong operating results for Roche in 2008   more..

Avastin and Tarceva in combination significantly improves the time patients with advanced lung cancer can live without their disease worsening   more..
January 2009
Roche intends to commence tender offer to acquire all shares of Genentech for US$ 86.50 per share in cash   more..

Roche delighted about pool extension   more..

MabThera receives positive opinion in Europe for first-line treatment for chronic lymphocytic leukaemia   more..

RoACTEMRA approved in Europe to treat patients suffering from Rheumatoid Arthritis   more..
December 2008
MabThera inhibits the destruction of joints in patients with early rheumatoid arthritis   more..

Herceptin given prior to surgery improves the chance of survival without relapse for women with HER2-positive breast cancer   more..

New data show that Herceptin, Xeloda and Avastin help patients with early and advanced breast cancer live longer or remain disease free for longer   more..

New data from largest-ever clinical trials in CLL show MabThera enables leukaemia patients to live longer without their disease progressing   more..

European Commission approval of new indication for Roche's Pegasys offers hepatitis C patients a second chance for a cure   more..

Roche and FDA Agree on Pathway Towards U.S. Approval of Actemra (tocilizumab)   more..

6th Roche Children's Walk: some 14'000 employees from 100 sites worldwide walk today to support children in need   more..
November 2008
Supporting modern standards of corporate governance   more..

Roche signs definitive agreement to acquire Memory Pharmaceuticals   more..

New phase III study of Avastin in advanced breast cancer meets its primary endpoint of increasing the time patients live without their disease getting worse   more..

RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis   more..

Tarceva brings new hope to patients with advanced non-small cell lung cancer   more..

Clinical studies as a logistical challenge   more..
October 2008
Roche posts sustained double-digit sales growth for the first nine months of 2008   more..

Pivotal Phase III study shows MabThera delays disease progression in patients with relapsed or refractory Chronic Lymphocytic Leukaemia   more..

Roche announces topline outcomes for Avastin-Tarceva combination study in advanced lung cancer   more..

Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy   more..

Roche invests 215 million Swiss francs in diagnostics facility at Penzberg   more..
September 2008
New data confirms Avastin as the only biologic to demonstrate overall survival when used first-line in metastatic colorectal cancer patients with K-RAS (wild-type) gene status   more..

Roche to present data showing progress in treating lung, gastric and brain cancers at ESMO   more..
August 2008
Chocos Village Project: contributions from Roche make a difference   more..

Parallel imports of patented drugs: a critical reflexion   more..

Blood Screening Team Wins 'Gold' at Olympic Games   more..

Roche and Meda agree on product transactions   more..

Roche continues to believe its Genentech proposal is fair and generous   more..

Roche Continents: creativity and innovation in Arts and Science   more..
July 2008
FDA Advisory Committee recommends approval of Actemra for the treatment of rheumatoid arthritis   more..

Using a novel sequencing system within RNAi therapeutic research   more..

Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics   more..

Roche acquires Mirus to advance research in the field of RNAi delivery   more..

Roche posts very good results: strong market outperformance - guidance confirmed   more..

Experts in a dialogue on genetics and ethics   more..
June 2008
European approval for Roche`s Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment   more..

New data reveals Actemra is the first and only biologic drug to show superiority over current standard of care in rheumatoid arthritis   more..

Roche moves investigational diabetes drug, Taspoglutide, into Phase III clinical trials   more..

Animal protection plays an important role in innovative research   more..
May 2008
Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer   more..

Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer   more..

Sustainability at Roche - an overview   more..

New Global Roche Position: Pharmaceuticals in the Environment   more..
April 2008
Roche employees support gift charity for Indian children   more..

Roche continues solid sales growth in first quarter of 2008 - both divisions significantly outpace their markets   more..

Actemra approved in Japan to treat patients with rheumatoid arthritis   more..

Alzheimer, a disease worth researching   more..

Roche fully acquires privately-owned biotech company Piramed   more..
March 2008
Roche says drug for cholesterol does well in tests   more..

New Roche Energy Efficiency Standard Translates Commitment Into Action   more..

Developing a new generation of diagnostics systems   more..

Roche raises dividend by 35 percent   more..
February 2008
Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer   more..

FDA grants accelerated approval of Avastin in combination with paclitaxel chemotherapy for first-line treatment of patients with advanced HER2-negative breast cancer   more..

Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint   more..

CNS Biomarker Day in Basel: bridging the gap between Pharma Research and Pharma Development   more..

Conducting research experiments with great speed   more..
January 2008
Roche helps African, Asian companies make AIDS drug   more..

Successful cooperation: from scientific breakthrough to therapy   more..
December 2007
PCR - test method enriching medical diagnosis   more..
November 2007
Roche arthritis drug effective in late-stage trial   more..
October 2007
Roche Considering Legal Options In Patent Litigation Case   more..

Tarceva approved for lung cancer in Japan   more..

European licence for Roche HIV drug Viracept re-established by European Commission   more..

Pivotal Mircera study first to convert dialysis patients from frequent dosing directly to once every four weeks   more..

Japanese Red Cross selects Roche as partner for nucleic acid screening of entire Japanese blood supply   more..
© 2007 Roche Pakistan Limited. Legal Statement - Privacy Policy.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.